Pds biotech announces conference call and webcast for full year 2024 financial results

Princeton, n.j., march 18, 2025 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the company will host a conference call to report financial results for the year ended december 31, 2024, and provide a clinical programs update on thursday, march 27, 2025, at 8:00 a.m.
PDS Ratings Summary
PDS Quant Ranking